PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
CURE vs. RWJ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

CURE vs. RWJ

Last updated Jun 13, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and RWJ (Invesco S&P SmallCap 600 Revenue ETF) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while RWJ is a Small Cap Value Equities fund tracking the S&P SmallCap 600 Revenue-Weighted Index. Both are passively managed. Over the past 10 years, CURE returned 13.49%/yr vs 13.64%/yr for RWJ. A 0.52 correlation means they provide meaningful diversification when combined. CURE charges 1.08%/yr vs 0.39%/yr for RWJ.

Performance

CURE vs. RWJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Invesco S&P SmallCap 600 Revenue ETF (RWJ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -7.96% return, which is significantly lower than RWJ's 21.05% return. Both investments have delivered pretty close results over the past 10 years, with CURE having a 13.49% annualized return and RWJ not far ahead at 13.64%.

CURE

1D
-0.55%
1M
13.71%
YTD
-7.96%
6M
-6.00%
1Y
28.51%
3Y*
3.05%
5Y*
1.51%
10Y*
13.49%

RWJ

1D
1.08%
1M
7.83%
YTD
21.05%
6M
17.99%
1Y
42.98%
3Y*
17.13%
5Y*
8.52%
10Y*
13.64%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. RWJ - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares		-7.96%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%
RWJ
Invesco S&P SmallCap 600 Revenue ETF		21.05%7.75%11.81%16.21%-10.97%52.82%20.83%20.29%-16.95%5.30%

Correlation

The correlation between CURE and RWJ is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.43

Correlation (3Y)
Calculated over the trailing 3-year period

0.43

Correlation (5Y)
Calculated over the trailing 5-year period

0.46

Correlation (10Y)
Calculated over the trailing 10-year period

0.46

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2011

0.52

The correlation between CURE and RWJ has been stable across timeframes, ranging from 0.43 to 0.52 - a consistent structural relationship.

CURE vs. RWJ - Sectors Allocation Comparison

Sectors
CURE
RWJ

Healthcare

100.0%
11.2%

Basic Materials

-

5.2%

Communication Services

-

3.3%

Consumer Cyclical

-

23.9%

Consumer Defensive

-

6.9%

Energy

-

7.4%

Financial Services

-

11.0%

Industrials

-

16.2%

Real Estate

-

4.0%

Technology

-

9.9%

Utilities

-

0.9%

Healthcare

CURE
100.0%
RWJ
11.2%

Basic Materials

CURE

-

RWJ
5.2%

Communication Services

CURE

-

RWJ
3.3%

Consumer Cyclical

CURE

-

RWJ
23.9%

Consumer Defensive

CURE

-

RWJ
6.9%

Energy

CURE

-

RWJ
7.4%

Financial Services

CURE

-

RWJ
11.0%

Industrials

CURE

-

RWJ
16.2%

Real Estate

CURE

-

RWJ
4.0%

Technology

CURE

-

RWJ
9.9%

Utilities

CURE

-

RWJ
0.9%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Direxion Daily Healthcare Bull 3x Shares

Invesco S&P SmallCap 600 Revenue ETF

Often compared with CURE:
CURE vs. XLVCURE vs. RXLCURE vs. PILLCURE vs. UTSLCURE vs. CNRGCURE vs. CWEBCURE vs. RETL
Often compared with RWJ:
RWJ vs. AVUVXRWJ vs. XSVMRWJ vs. RZVRWJ vs. RWKRWJ vs. CALFRWJ vs. RFVRWJ vs. FSMD

Return for Risk

CURE vs. RWJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
CURE
CURE Risk / Return Rank: 2121
Overall Rank
CURE Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2424
Sortino Ratio Rank
CURE Omega Ratio Rank: 2222
Omega Ratio Rank
CURE Calmar Ratio Rank: 2222
Calmar Ratio Rank
CURE Martin Ratio Rank: 1919
Martin Ratio Rank
RWJ
RWJ Risk / Return Rank: 7474
Overall Rank
RWJ Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
RWJ Sortino Ratio Rank: 7777
Sortino Ratio Rank
RWJ Omega Ratio Rank: 6969
Omega Ratio Rank
RWJ Calmar Ratio Rank: 7878
Calmar Ratio Rank
RWJ Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. RWJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Invesco S&P SmallCap 600 Revenue ETF (RWJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

CURERWJDifference
Sharpe ratioReturn per unit of total volatility
0.60
2.07

-1.47

Sortino ratioReturn per unit of downside risk
1.18
2.95

-1.77

Omega ratioGain probability vs. loss probability

1.13

1.35

-0.22

Calmar ratioReturn relative to maximum drawdown

0.85

3.56

-2.70

Martin ratioReturn relative to average drawdown

1.94

11.43

-9.49

CURE vs. RWJ - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.60, which is lower than the RWJ Sharpe Ratio of 2.07. The chart below compares the historical Sharpe Ratios of CURE and RWJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

CURE vs. RWJ - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, which is greater than RWJ's maximum drawdown of -55.97%. Use the drawdown chart below to compare losses from any high point for CURE and RWJ.

Loading charts...

Drawdown Indicators

CURERWJDifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-55.97%

-13.22%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-11.31%

-19.79%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-29.29%

-22.64%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-29.29%

-22.94%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

-51.33%

-17.86%

Current Drawdown

Current decline from peak

-26.94%

0.00%

-26.94%

Average Drawdown

Average peak-to-trough decline

-18.16%

-9.22%

-8.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.71%

3.52%

+10.19%

Volatility

CURE vs. RWJ - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.30% compared to Invesco S&P SmallCap 600 Revenue ETF (RWJ) at 4.67%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than RWJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

CURERWJDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.30%

4.67%

+9.63%

Volatility (6M)

Calculated over the trailing 6-month period

30.87%

12.46%

+18.41%

Volatility (1Y)

Calculated over the trailing 1-year period

44.32%

19.48%

+24.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.84%

23.71%

+20.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.59%

26.14%

+23.45%

CURE vs. RWJ - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than RWJ's 0.39% expense ratio.

Dividends

CURE vs. RWJ - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.16%, more than RWJ's 0.97% yield.

PositionTTM20252024202320222021202020192018201720162015
CURE
Direxion Daily Healthcare Bull 3x Shares		1.16%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%
RWJ
Invesco S&P SmallCap 600 Revenue ETF		0.97%1.11%1.15%1.34%1.02%0.61%0.89%1.22%1.44%1.11%0.60%0.74%

Frequently Asked Questions

CURE and RWJ have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (14.30%) compared to RWJ (4.67%). In terms of maximum drawdown, CURE dropped -69.19% vs RWJ's -55.97%.

On 10-year performance, RWJ leads with 13.64% vs 13.49% for CURE. On fees, RWJ is cheaper at 0.39% per year. On volatility, RWJ has been the lower-risk option at 4.67%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, RWJ has performed better with a 13.64% return vs 13.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

RWJ is cheaper with a 0.39% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.16%, compared with 0.97% for RWJ.

CURE is categorized as Leveraged Equities, while RWJ is Small Cap Value Equities. CURE tracks Health Care Select Sector Index (300%), while RWJ tracks S&P SmallCap 600 Revenue-Weighted Index. They also come from different issuers: Direxion and Invesco. Their fees differ too: 1.08% for CURE and 0.39% for RWJ.

RWJ currently has the higher Sharpe Ratio (2.07 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and RWJ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer